Published in Psychooncology on December 17, 2012
Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer (2015) 3.55
Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav Immun (2014) 1.09
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience (2016) 0.76
The Sedative Effect of Propranolol on Critically Ill Patients: A Case Series. Front Med (Lausanne) (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol (1988) 26.07
Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med (2008) 7.21
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res (2006) 3.58
The perseverative cognition hypothesis: a review of worry, prolonged stress-related physiological activation, and health. J Psychosom Res (2006) 3.49
The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res (2010) 3.36
Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res (2007) 3.19
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry (2002) 3.15
Applying learning principles to the treatment of post-trauma reactions. Ann N Y Acad Sci (2003) 3.05
Role of adrenal stress hormones in forming lasting memories in the brain. Curr Opin Neurobiol (2002) 3.02
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res (2006) 2.32
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry (2003) 2.17
Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. J Consult Clin Psychol (1995) 1.82
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun (2008) 1.71
Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart (2003) 1.69
Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors--a meta-analysis. Psychooncology (2011) 1.68
Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol (1999) 1.65
beta-Blocker therapy in heart failure: scientific review. JAMA (2002) 1.62
Stress-related noradrenergic activity prompts large-scale neural network reconfiguration. Science (2011) 1.55
Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. Am J Psychiatry (2006) 1.51
Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress (2002) 1.40
Traumatic stress, perceived global stress, and life events: prospectively predicting quality of life in breast cancer patients. Health Psychol (2005) 1.38
Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients. J Trauma Stress (2007) 1.36
Posttraumatic growth and PTSD symptomatology among colorectal cancer survivors: a 3-month longitudinal examination of cognitive processing. Psychooncology (2009) 1.31
Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J (2008) 1.30
Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther (2011) 1.27
PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress (2008) 1.25
Trauma reactivation under the influence of propranolol decreases posttraumatic stress symptoms and disorder: 3 open-label trials. J Clin Psychopharmacol (2011) 1.24
Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology (Berl) (2006) 1.22
Emerging treatments for PTSD. Clin Psychol Rev (2009) 1.21
Experience of trauma, distress, and posttraumatic stress disorder among breast cancer patients. Psychosom Med (2004) 1.20
Adjustment to breast cancer: age-related differences in coping and emotional distress. Breast Cancer Res Treat (1999) 1.08
Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am (2011) 1.04
An investigation of the cognitive and experiential features of intrusive memories in depression. Memory (2007) 0.98
Expanding our therapeutic options: Beta blockers for breast cancer? J Clin Oncol (2011) 0.94
Intrusive thoughts and avoidance in breast cancer: Individual differences and association with psychological distress. Psychol Health (2000) 0.88
Contingent negative variation and efficacy of beta-blocking agents in migraine. Cephalalgia (1986) 0.87
Long term propranolol treatment and changes in body weight after myocardial infarction. BMJ (1990) 0.86
A beta-adrenergic antagonist reduces traumatic memories and PTSD symptoms in female but not in male patients after cardiac surgery. Psychol Med (2009) 0.84
β-blockers and the risk of incident depression in the elderly. J Clin Psychopharmacol (2011) 0.84
Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol. Am J Cardiovasc Drugs (2006) 0.83
The effect of acute beta-adrenoceptor blockade on examination performance. Br J Clin Pharmacol (1985) 0.83
Stress-induced immune dysfunction: implications for health. Nat Rev Immunol (2005) 5.75
Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst (2012) 3.87
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer (2008) 3.68
Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev (2013) 3.40
Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev (2011) 3.33
Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol (2007) 3.20
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
The physiology of marriage: pathways to health. Physiol Behav (2003) 3.15
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. J Clin Oncol (2011) 2.87
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. Lancet Oncol (2013) 2.59
Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol (2004) 2.55
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial. J Clin Oncol (2008) 2.55
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring) (2011) 2.08
Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol (2002) 2.07
Design and analysis of group-randomized trials in cancer: a review of current practices. J Natl Cancer Inst (2008) 2.05
Can't see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol (2013) 2.04
Thyroid carcinoma. J Natl Compr Canc Netw (2010) 2.02
Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med (2011) 1.90
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
Parental cancer and the family: a population-based estimate of the number of US cancer survivors residing with their minor children. Cancer (2010) 1.83
Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.79
Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Res (2010) 1.76
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest (2002) 1.74
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood (2004) 1.73
Giant breast tumors: surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature. World J Surg Oncol (2008) 1.73
Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry (2003) 1.66
Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol (2012) 1.66
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines. Clin Cancer Res (2007) 1.66
Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab (2010) 1.65
Breast cancer version 3.2014. J Natl Compr Canc Netw (2014) 1.63
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res (2011) 1.61
Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav Immun (2007) 1.59
Breast Cancer Version 2.2015. J Natl Compr Canc Netw (2015) 1.59
Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol (2006) 1.58
Stress, age, and immune function: toward a lifespan approach. J Behav Med (2006) 1.56
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res (2004) 1.55
Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv (2013) 1.55
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies. Mol Cancer Ther (2009) 1.54
Anaplastic thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.54
Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation (2008) 1.51
β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav Immun (2012) 1.50
Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res (2012) 1.50
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. Ann Surg Oncol (2007) 1.49
Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Ann Surg Oncol (2008) 1.48
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy. Cancer Immunol Immunother (2011) 1.47
Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol (2009) 1.46
Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.44
History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women. Metabolism (2012) 1.43
Invasive breast cancer. J Natl Compr Canc Netw (2011) 1.43
Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 1.42
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst (2004) 1.42
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.40
Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm (2009) 1.38
Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst (2013) 1.38
Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One (2007) 1.36
Cancer survivorship and cancer rehabilitation: revitalizing the link. J Clin Oncol (2012) 1.35
Psychological responses to cancer recurrence. Cancer (2005) 1.34
Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res (2007) 1.33
Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res (2006) 1.32
Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Clin Gastroenterol Hepatol (2006) 1.32
Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities. J Oncol Pract (2012) 1.31
Exercise accelerates wound healing among healthy older adults: a preliminary investigation. J Gerontol A Biol Sci Med Sci (2005) 1.30
Stress and wound healing. Neuroimmunomodulation (2007) 1.29
Mammary tuberculosis -- importance of recognition and differentiation from that of a breast malignancy: report of three cases and review of the literature. World J Surg Oncol (2007) 1.29
Breast cancer survivors' health-related quality of life : racial differences and comparisons with noncancer controls. Cancer (2008) 1.28
Hostility and pain are related to inflammation in older adults. Brain Behav Immun (2006) 1.28
Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials (2009) 1.27
Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2009) 1.27
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol Cancer (2010) 1.27
Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation. Psychoneuroendocrinology (2012) 1.26
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood (2008) 1.26
Who provides psychosocial follow-up care for post-treatment cancer survivors? A survey of medical oncologists and primary care physicians. J Clin Oncol (2012) 1.26
Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control (2011) 1.25
Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2010) 1.25
Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology (2011) 1.25
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production. J Immunol (2011) 1.25
Exercise-oncology research: past, present, and future. Acta Oncol (2012) 1.24
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol (2007) 1.23
Dietary weight loss and exercise interventions effects on quality of life in overweight/obese postmenopausal women: a randomized controlled trial. Int J Behav Nutr Phys Act (2011) 1.23
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.23
A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med (2009) 1.22
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab. Breast Cancer Res Treat (2008) 1.21
Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus. Horm Behav (2002) 1.19
Review of S100A9 biology and its role in cancer. Biochim Biophys Acta (2012) 1.19
The impact of psychological stress on wound healing: methods and mechanisms. Immunol Allergy Clin North Am (2011) 1.18
Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun (2006) 1.18
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest (2003) 1.17
Loneliness promotes inflammation during acute stress. Psychol Sci (2013) 1.17
Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation. Cancer (2005) 1.16